Filing Details
- Accession Number:
- 0001144204-18-015760
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2018-03-20 10:50:35
- Reporting Period:
- 2018-03-15
- Accepted Time:
- 2018-03-20 10:50:35
- Original Submission Date:
- 2018-03-16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1137883 | Brainstorm Cell Therapeutics Inc. | BCLI | Biological Products, (No Disgnostic Substances) (2836) | 207273918 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1492647 | Sherie June Almenoff | C/O Brainstorm Cell Therapeutics Inc. 1745 Broadway, 17Th Floor New York NY 10019 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-03-15 | 5,700 | $3.50 | 5,700 | No | 4 | P | Indirect | By Meadowlark Management LLC |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Meadowlark Management LLC |
Footnotes
- The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for the purposes of Section 16 or for any other purpose.
- This Form 4/A is being filed to reflect that this was an open market purchase of the Issuer's securities (On March 16, 2018 this transaction was incorrectly reported on Form 4 as an acquisition pursuant to Rule 16b-3(d).
Billionaire Hedge Funds
